3-iodobenzylguanidine has been researched along with Diabetic Retinopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anan, F; Eshima, N; Nakagawa, M; Saikawa, T; Takahashi, N; Takayuki, M; Yoshimatsu, H | 1 |
| Boy, C; Gries, FA; Hübinger, A; Langen, KJ; Müller-Gärtner, HW; Piolot, R; Weise, F; Ziegler, D | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and Diabetic Retinopathy
| Article | Year |
|---|---|
Diabetic retinopathy is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients.
Topics: 3-Iodobenzylguanidine; Anthropometry; Autonomic Nervous System Diseases; Baroreflex; Body Composition; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Echocardiography; Female; Heart Rate; Humans; Hypertension; Insulin Resistance; Japan; Logistic Models; Male; Middle Aged; Norepinephrine; Radionuclide Imaging | 2009 |
Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Biomarkers; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Diabetic Retinopathy; Electrocardiography; Female; Glycated Hemoglobin; Heart; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Peripheral Nerves; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Sympathetic Nervous System; Ventricular Function, Left | 1998 |